Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
Trial registration Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2018-06-01
|
| Series: | Arthritis Research & Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13075-018-1628-6 |
| id |
doaj-art-9c4e8ec4613a4145b7a6cfdaba2f8abb |
|---|---|
| recordtype |
oai_dc |
| spelling |
doaj-art-9c4e8ec4613a4145b7a6cfdaba2f8abb2018-08-20T18:28:47ZengBioMed CentralArthritis Research & Therapy1478-63622018-06-012011310.1186/s13075-018-1628-6Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritisElodie Rivière0Jérémie Sellam1Juliette Pascaud2Philippe Ravaud3Jacques-Eric Gottenberg4Xavier Mariette5Immunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM UMR1184Department of Rheumatology, Saint-Antoine HospitalImmunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM UMR1184Department of Epidemiology and Biostatistics, Hotel DieuDepartment of Rheumatology, National Reference Center for Systemic Autoimmune Diseases, Strasbourg University Hospital, Université de StrasbourgImmunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM UMR1184Trial registration Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441http://link.springer.com/article/10.1186/s13075-018-1628-6Interleukin 33Personalized medicineRheumatoid arthritisBiologic agents |
| institution |
Open Data Bank |
| collection |
Open Access Journals |
| building |
Directory of Open Access Journals |
| language |
English |
| format |
Article |
| author |
Elodie Rivière Jérémie Sellam Juliette Pascaud Philippe Ravaud Jacques-Eric Gottenberg Xavier Mariette |
| spellingShingle |
Elodie Rivière Jérémie Sellam Juliette Pascaud Philippe Ravaud Jacques-Eric Gottenberg Xavier Mariette Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis Arthritis Research & Therapy Interleukin 33 Personalized medicine Rheumatoid arthritis Biologic agents |
| author_facet |
Elodie Rivière Jérémie Sellam Juliette Pascaud Philippe Ravaud Jacques-Eric Gottenberg Xavier Mariette |
| author_sort |
Elodie Rivière |
| title |
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| title_short |
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| title_full |
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| title_fullStr |
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| title_full_unstemmed |
Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| title_sort |
serum il-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis |
| publisher |
BioMed Central |
| series |
Arthritis Research & Therapy |
| issn |
1478-6362 |
| publishDate |
2018-06-01 |
| description |
Trial registration Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441 |
| topic |
Interleukin 33 Personalized medicine Rheumatoid arthritis Biologic agents |
| url |
http://link.springer.com/article/10.1186/s13075-018-1628-6 |
| _version_ |
1612683789297778688 |